CINECA IRIS Institutional Research Information System

ARENA, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.025
EU - Europa 2.670
AS - Asia 2.268
OC - Oceania 148
SA - Sud America 55
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.212
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.847
IT - Italia 1.088
CN - Cina 1.043
GB - Regno Unito 301
DE - Germania 243
JP - Giappone 230
IL - Israele 203
FR - Francia 173
KR - Corea 155
CA - Canada 145
NL - Olanda 139
AU - Australia 125
IN - India 113
ES - Italia 112
HK - Hong Kong 103
CZ - Repubblica Ceca 76
FI - Finlandia 65
TR - Turchia 65
TW - Taiwan 65
CH - Svizzera 54
RU - Federazione Russa 53
SG - Singapore 48
VN - Vietnam 46
PL - Polonia 44
BE - Belgio 40
MY - Malesia 35
SE - Svezia 34
IE - Irlanda 33
ID - Indonesia 30
MX - Messico 30
RO - Romania 30
DK - Danimarca 28
PT - Portogallo 24
NZ - Nuova Zelanda 23
AT - Austria 19
UA - Ucraina 19
GR - Grecia 18
HU - Ungheria 18
BR - Brasile 17
TH - Thailandia 17
CL - Cile 16
PH - Filippine 15
SA - Arabia Saudita 15
JO - Giordania 14
ZA - Sudafrica 13
IR - Iran 12
PK - Pakistan 11
SK - Slovacchia (Repubblica Slovacca) 10
MO - Macao, regione amministrativa speciale della Cina 9
NO - Norvegia 9
CO - Colombia 8
EG - Egitto 7
MK - Macedonia 7
AR - Argentina 5
DZ - Algeria 5
KZ - Kazakistan 5
LT - Lituania 5
NG - Nigeria 5
PS - Palestinian Territory 5
RS - Serbia 5
SI - Slovenia 5
TN - Tunisia 5
BY - Bielorussia 4
EC - Ecuador 4
KW - Kuwait 4
LB - Libano 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BN - Brunei Darussalam 3
IQ - Iraq 3
PR - Porto Rico 3
QA - Qatar 3
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
LU - Lussemburgo 2
LY - Libia 2
MA - Marocco 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
SC - Seychelles 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KE - Kenya 1
LV - Lettonia 1
SM - San Marino 1
TZ - Tanzania 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 8.212
Salva come PNG Salva come JPEG
Città #
Fairfield 199
Houston 178
Beijing 148
Shanghai 144
Ashburn 139
Turin 123
Torino 120
Woodbridge 119
Santa Cruz 118
Guangzhou 100
Seattle 97
Buffalo 92
Tel Aviv 81
Cambridge 78
Milan 73
Ann Arbor 70
Wilmington 70
Tokyo 62
Nanjing 61
New York 60
Rome 54
Carrara 48
Wuhan 48
Taipei 47
Lappeenranta 45
Chicago 43
Brescia 41
Hangzhou 38
Manchester 37
Seoul 36
Dong Ket 35
Central District 32
Los Angeles 32
Barcelona 31
Chengdu 31
Ottawa 31
Seongnam 31
London 30
Simi Valley 27
Changsha 26
Toronto 26
San Diego 25
San Francisco 23
Central 21
Redmond 21
Duncan 20
Liverpool 20
Mumbai 19
Shenyang 19
Boston 18
Helsinki 18
University Park 18
Warsaw 18
Ankara 17
Norwalk 17
Ramat Gan 17
Dunfermline 16
Genoa 16
Paris 16
Vienna 16
Amsterdam 15
Brisbane 15
Burlington 15
Dallas 15
Istanbul 15
Pisa 15
Bengaluru 14
Birmingham 14
Boardman 14
Council Bluffs 14
Dublin 14
Dundee 14
Jinan 14
Miami 14
Singapore 14
Utrecht 14
Fuzhou 13
Kuala Lumpur 13
Las Vegas 13
Melbourne 13
San Jose 13
Sutton Coldfield 13
Xian 13
Zurich 13
Berlin 12
Columbus 12
Delhi 12
Jakarta 12
Naples 12
Philadelphia 12
Chaoyang 11
Har Adar 11
Iowa City 11
Ithaca 11
Luni 11
Miaoli 11
Muizenberg 11
Munich 11
Nanchang 11
Pittsburgh 11
Totale 3.772
Salva come PNG Salva come JPEG
Nome #
High-dose Vitamin C enhances cancer immunotherapy, file e27ce42f-de1f-2581-e053-d805fe0acbaa 2.293
EGFR blockade reverts resistance to KRAS G12C inhibition in colorectal cancer, file e27ce430-1013-2581-e053-d805fe0acbaa 1.087
Adaptive mutability of colorectal cancers in response to targeted therapies, file e27ce42e-f361-2581-e053-d805fe0acbaa 873
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer, file e27ce426-f447-2581-e053-d805fe0acbaa 671
BRAF V600E is a determinant of sensitivity to proteasome inhibitors., file e27ce426-ffd1-2581-e053-d805fe0acbaa 482
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer, file e27ce42e-fdba-2581-e053-d805fe0acbaa 361
Characterization of tumor-derived mesenchymal stem cells potentially differentiating into cancer-associated fibroblasts in lung cancer, file e27ce42e-b916-2581-e053-d805fe0acbaa 304
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer, file e27ce427-2d1b-2581-e053-d805fe0acbaa 291
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer, file e27ce42a-9432-2581-e053-d805fe0acbaa 216
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations, file e27ce428-9706-2581-e053-d805fe0acbaa 204
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce428-ee7a-2581-e053-d805fe0acbaa 184
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, file e27ce431-ae7a-2581-e053-d805fe0acbaa 172
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer, file ec9c2092-a53b-4286-be12-aa515de4f3e9 152
Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1, file e27ce42a-8f8a-2581-e053-d805fe0acbaa 133
The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase., file e27ce428-5e56-2581-e053-d805fe0acbaa 129
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer, file e27ce42f-ed2c-2581-e053-d805fe0acbaa 113
Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies, file e27ce42d-8304-2581-e053-d805fe0acbaa 107
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistance, file e27ce42c-b2a5-2581-e053-d805fe0acbaa 104
TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors, file 2a9b9aad-9b03-41b3-9423-b8b115aae403 88
Preclinical models as patients’ avatars for precision medicine in colorectal cancer: past and future challenges, file e27ce431-d429-2581-e053-d805fe0acbaa 83
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin, file e27ce435-7e08-2581-e053-d805fe0acbaa 75
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy, file e27ce432-19bb-2581-e053-d805fe0acbaa 66
BRAF V600E is a determinant of sensitivity to proteasome inhibitors., file e27ce426-ffd2-2581-e053-d805fe0acbaa 63
Empowering Clinical Decision Making in Oligometastatic Colorectal Cancer: The Potential Role of Drug Screening of Patient-Derived Organoids, file e27ce432-8c4d-2581-e053-d805fe0acbaa 58
A Subset of Colorectal Cancers with Cross-Sensitivity to Olaparib and Oxaliplatin, file e27ce42f-3951-2581-e053-d805fe0acbaa 30
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study, file e27ce434-adc7-2581-e053-d805fe0acbaa 23
The first-in-class anti-EGFR antibody mixture Sym004 overcomes cetuximab resistance mediated by EGFR extracellular domain mutations in colorectal cancer, file e27ce429-add3-2581-e053-d805fe0acbaa 20
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient, file d82de37f-401b-46a4-8b57-899917d6fc66 9
Adaptive mutability of colorectal cancers in response to targeted therapies, file e27ce42e-f362-2581-e053-d805fe0acbaa 8
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce432-5e80-2581-e053-d805fe0acbaa 8
Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT), file 106a6aac-a35e-4286-a00d-8cde54a95bd1 5
High-dose Vitamin C enhances cancer immunotherapy, file e27ce430-8110-2581-e053-d805fe0acbaa 5
The first-in-class anti-EGFR antibody mixture Sym004 overcomes cetuximab resistance mediated by EGFR extracellular domain mutations in colorectal cancer, file e27ce429-add4-2581-e053-d805fe0acbaa 3
The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer, file e27ce430-a005-2581-e053-d805fe0acbaa 3
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations, file e27ce432-5371-2581-e053-d805fe0acbaa 3
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cells, file 3e565933-39af-42ed-ac88-ac0df80cb2b3 2
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer, file e27ce428-9ee6-2581-e053-d805fe0acbaa 2
Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer, file e27ce432-5370-2581-e053-d805fe0acbaa 2
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy, file e78d2eaa-9fe7-4e13-a3d9-e26539b5fc4a 2
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer, file b44dea87-deb2-4358-9a38-4ac3efb24632 1
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer, file e27ce426-e418-2581-e053-d805fe0acbaa 1
Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab., file e27ce426-e630-2581-e053-d805fe0acbaa 1
Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus., file e27ce426-e633-2581-e053-d805fe0acbaa 1
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations, file e27ce428-9900-2581-e053-d805fe0acbaa 1
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer, file e27ce429-cb90-2581-e053-d805fe0acbaa 1
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities, file e27ce430-c2e5-2581-e053-d805fe0acbaa 1
Totale 8.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 0 81 43
2019/2020884 50 34 42 68 39 33 43 104 123 94 94 160
2020/20212.254 180 186 218 220 204 231 227 142 213 178 117 138
2021/20222.289 171 136 161 279 243 186 210 146 261 126 215 155
2022/20232.196 115 135 367 302 157 131 132 263 276 211 89 18
2023/2024247 3 8 22 12 22 25 24 38 13 62 18 0
Totale 8.441